Champions Oncology
CSBR
37 hedge funds and large institutions have $46.7M invested in Champions Oncology in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 7 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.44% less ownership
Funds ownership: 52.8% → 51.36% (-1.4%)
3% less funds holding
Funds holding: 38 → 37 (-1)
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
22% less capital invested
Capital invested by funds: $60.1M → $46.7M (-$13.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$686K |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$511K |
| 3 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
+$311K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$196K |
| 5 |
BlackRock
New York
|
+$129K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.24M |
| 2 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$790K |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$459K |
| 4 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$282K |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$194K |
CSBR Hedge Fund Activity: Q2 2019 in Review
37 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q2 2019, worth a combined $46.7M — down 22% from $60.1M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of CSBR and 6 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 9 added.
The largest buyer was Wells Fargo, adding an estimated $686K. The largest seller was Schonfeld Strategic Advisors, exiting entirely with an estimated $1.24M sold.
- 37 institutional investors held Champions Oncology (CSBR) as of Q2 2019, down from 38 in Q1 2019.
- Funds reported $46.7M of Champions Oncology stock for Q2 2019, down 22% quarter-over-quarter.
- 6 funds opened new Champions Oncology positions in Q2 2019 and 7 closed out, a net change of -1 holder.
- The largest Champions Oncology buyer in Q2 2019 was Wells Fargo, an estimated $686K added.
- The largest Champions Oncology seller in Q2 2019 was Schonfeld Strategic Advisors, an estimated $1.24M sold.
Based on aggregated 13F filings for Q2 2019.